Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation

@inproceedings{Lindner2009BetaescinHP,
  title={Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation},
  author={Ines Lindner and Christiane Meier and Angelika Url and Hermann Unger and Andreas Grassauer and Eva Prieschl-Grassauer and Petra Doerfler},
  booktitle={BMC Immunology},
  year={2009}
}
Type I hypersensitivity is characterized by the overreaction of the immune system against otherwise innocuous substances. It manifests as allergic rhinitis, allergic conjunctivitis, allergic asthma or atopic dermatitis if mast cells are activated in the respective organs. In case of systemic mast cell activation, life-threatening anaphylaxis may occur. Currently, type I hypersensitivities are treated either with glucocorticoids, anti-histamines, or mast cell stabilizers. Although these drugs… CONTINUE READING
10 Citations
41 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Similar Papers

Loading similar papers…